Genzyme/Sanofi merger positions firms with two leading drugs

A board to discuss the soon-to-be released drug Campath as a treatment for Multiple Sclerosis

Genzyme/Sanofi merger positions firms with two leading drugs

Postby MSUK » Tue Apr 26, 2011 11:56 pm

Image

Genzyme which plans to announce pivotal results from its program evaluating Campath in multiple sclerosis later this year, is also interested in broadening its portfolio in this indication, said Dr Michael Panzara.

The company remains committed to researching the drug’s effect on the autoimmune system in light of certain side-effects seen in trials, said Panzara, who is group vice president of multiple sclerosis and immune diseases at Genzyme.

Campath (alemtuzumab) is a chemotherapy drug that is currently used to treat B-cell chronic lymphocytic leukemia....Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1307
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2188
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Campath (Lemtrada, Alemtuzumab)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service